Citigroup’s Herbalife HLF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.15M | Sell |
350,000
-441,000
| -56% | -$7.2M | ﹤0.01% | 1945 |
|
|
2025
Q4 | $10.2M | Buy |
791,000
+350,000
| +79% | +$3.71M | ﹤0.01% | 1516 |
|
|
2025
Q3 | $3.72M | Hold |
441,000
| – | – | ﹤0.01% | 2194 |
|
|
2025
Q2 | $3.8M | Hold |
441,000
| – | – | ﹤0.01% | 2102 |
|
|
2025
Q1 | $3.81M | Hold |
441,000
| – | – | ﹤0.01% | 2160 |
|
|
2024
Q4 | $2.95M | Buy |
441,000
+361,500
| +455% | +$2.69M | ﹤0.01% | 2470 |
|
|
2024
Q3 | $572K | Hold |
79,500
| – | – | ﹤0.01% | 3644 |
|
|
2024
Q2 | $826K | Buy |
+79,500
| New | +$794K | ﹤0.01% | 3047 |
|
|
2022
Q4 | – | Sell |
-100,000
| Closed | -$1.99M | – | 5842 |
|
|
2022
Q3 | $1.99M | Buy |
+100,000
| New | +$2.48M | ﹤0.01% | 2144 |
|
|
2021
Q1 | – | Sell |
-25,700
| Closed | -$1.24M | – | 6743 |
|
|
2020
Q4 | $1.24M | Sell |
25,700
-7,800
| -23% | -$376K | ﹤0.01% | 3330 |
|
|
2020
Q3 | $1.56M | Sell |
33,500
-143,600
| -81% | -$7.05M | ﹤0.01% | 2885 |
|
|
2020
Q2 | $7.97M | Buy |
177,100
+115,300
| +187% | +$4.48M | 0.01% | 1485 |
|
|
2020
Q1 | $1.8M | Sell |
61,800
-79,800
| -56% | -$2.97M | ﹤0.01% | 2583 |
|
|
2019
Q4 | $6.75M | Sell |
141,600
-234,700
| -62% | -$10.2M | ﹤0.01% | 1783 |
|
|
2019
Q3 | $14.2M | Buy |
376,300
+200,400
| +114% | +$7.82M | 0.01% | 1151 |
|
|
2019
Q2 | $7.52M | Sell |
175,900
-240,100
| -58% | -$11.4M | 0.01% | 1613 |
|
|
2019
Q1 | $22M | Buy |
416,000
+21,200
| +5% | +$1.22M | 0.02% | 774 |
|
|
2018
Q4 | $23.3M | Buy |
394,800
+197,200
| +100% | +$10.9M | 0.02% | 736 |
|
|
2018
Q3 | $10.8M | Sell |
197,600
-193,700
| -50% | -$10.7M | 0.01% | 1235 |
|
|
2018
Q2 | $21M | Buy |
391,300
+22,100
| +6% | +$1.16M | 0.02% | 774 |
|
|
2018
Q1 | $18M | Sell |
369,200
-141,200
| -28% | -$5.99M | 0.01% | 842 |
|
|
2017
Q4 | $17.3M | Sell |
510,400
-731,400
| -59% | -$25.6M | 0.01% | 930 |
|
|
2017
Q3 | $42.1M | Buy |
1,241,800
+275,400
| +28% | +$9.43M | 0.03% | 473 |
|
|
2017
Q2 | $34.5M | Buy |
966,400
+388,600
| +67% | +$13.1M | 0.03% | 495 |
|
|
2017
Q1 | $16.8M | Sell |
577,800
-94,000
| -14% | -$2.61M | 0.02% | 828 |
|
|
2016
Q4 | $16.2M | Buy |
671,800
+158,800
| +31% | +$4.34M | 0.01% | 884 |
|
|
2016
Q3 | $15.9M | Sell |
513,000
-49,400
| -9% | -$1.56M | 0.01% | 812 |
|
|
2016
Q2 | $16.5M | Buy |
562,400
+39,800
| +8% | +$1.19M | 0.02% | 731 |
|
|
2016
Q1 | $16.1M | Sell |
522,600
-945,600
| -64% | -$24.4M | 0.02% | 717 |
|
|
2015
Q4 | $39.4M | Buy |
1,468,200
+477,200
| +48% | +$13.3M | 0.04% | 446 |
|
|
2015
Q3 | $27M | Sell |
991,000
-110,800
| -10% | -$3.04M | 0.03% | 577 |
|
|
2015
Q2 | $30.3M | Buy |
1,101,800
+87,600
| +9% | +$2.12M | 0.03% | 581 |
|
|
2015
Q1 | $21.7M | Sell |
1,014,200
-836,600
| -45% | -$14.3M | 0.02% | 726 |
|
|
2014
Q4 | $34.9M | Buy |
1,850,800
+23,000
| +1% | +$492K | 0.03% | 548 |
|
|
2014
Q3 | $40M | Buy |
1,827,800
+163,200
| +10% | +$4.36M | 0.04% | 477 |
|
|
2014
Q2 | $53.7M | Sell |
1,664,600
-142,000
| -8% | -$4.35M | 0.05% | 332 |
|
|
2014
Q1 | $51.7M | Sell |
1,806,600
-1,959,600
| -52% | -$64.7M | 0.05% | 317 |
|
|
2013
Q4 | $148M | Buy |
3,766,200
+464,600
| +14% | +$16.1M | 0.13% | 116 |
|
|
2013
Q3 | $115M | Buy |
3,301,600
+1,351,200
| +69% | +$41.8M | 0.11% | 152 |
|
|
2013
Q2 | $44M | Buy |
+1,950,400
| New | +$41.5M | 0.04% | 356 |
|
Other funds holding HLF
BG
ROIC
VPM
VCM
Citigroup's HLF Position: Q1 2026 in Review
Citigroup reduced its Herbalife (HLF) stake by 31% in Q1 2026, selling an estimated $8.37M and leaving 1,162,649 shares worth $17.1M. The position accounts for 0.01% of the portfolio, ranked #1159.
Citigroup first reported a position in HLF in Q2 2013 and has held it in 52 quarters since. The position peaked at $42M in Q2 2020. 252 funds tracked by Wall St. Rank hold HLF as of Q1 2026.
- Citigroup held 1,162,649 shares of Herbalife worth $17.1M as of Q1 2026.
- Citigroup sold 512,480 Herbalife shares in Q1 2026, an estimated $8.37M.
- Herbalife made up 0.01% of Citigroup's portfolio in Q1 2026, its #1159 holding.
- Citigroup first reported a position in Herbalife in Q2 2013 and has held it in 52 quarters since.
- Citigroup's Herbalife position peaked at $42M in Q2 2020.
- 252 funds tracked by Wall St. Rank held Herbalife as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.